Claire Harrison, MD

Videos

MAJIC-PV Study Indicates Ruxolitinib Treatment Yields Superior Responses for Patients With Polycythemia Vera

06/21/2023

Claire Harrison, MD, presents results from the phase 2 MAGIC-PV trial, which indicate that ruxolitinib treatment yielded superior event-free survival and complete responses vs best available therapy for patients with...

Claire Harrison, MD, presents...

06/21/2023

Oncology

Claire Harrison, MD, FRCP, Guy’s and St. Thomas’ NHS Foundation Trust

Conference Coverage

Ruxolitinib Therapy Demonstrates Reduced JAK2 Allele Burden and Improvement in Hematocrit Control and Symptom Burden for Patients With PV

12/21/2023

Claire Harrison , MD;

At the 65th ASH Annual Meeting in San Diego, California, Claire Harrison, MD, FRCP discussed a pooled efficacy analysis that provided further evidence of the benefit of ruxolitinib treatment for patients with polycythemia vera, with or...

At the 65th ASH Annual Meeting...

12/21/2023

Oncology